These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3880569)

  • 21. T cell lineages in the thymus of lpr/lpr mice. Evidence for parallel pathways of normal and abnormal T cell development.
    Budd RC; Schreyer M; Miescher GC; MacDonald HR
    J Immunol; 1987 Oct; 139(7):2200-10. PubMed ID: 3498754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-2 receptor expression in autoimmune MRL-lpr/lpr mice. The expanded L3T4-, Lyt-2- population does not express p75 and cannot generate functional high-affinity IL-2 receptors.
    Rosenberg YJ; Nurse F; Begley CG
    J Immunol; 1989 Oct; 143(7):2216-22. PubMed ID: 2789257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cultured Lyt-2- L3T4- T lymphocytes from normal thymus or lpr mice express a broad spectrum of cytolytic activity.
    Budd RC; Cerottini JC; MacDonald HR
    J Immunol; 1986 Dec; 137(12):3734-41. PubMed ID: 3491147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
    Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
    J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of immature (Lyt-2-/L3T4-) thymocytes. Identification of four major phenotypically distinct subsets differing in cell cycle status and in vitro activation requirements.
    Howe RC; MacDonald HR
    J Immunol; 1988 Feb; 140(4):1047-55. PubMed ID: 3257768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired AMLR in autoimmunity.
    Talal N; Fischbach M; Dauphinee M
    Behring Inst Mitt; 1983 May; (72):169-76. PubMed ID: 6242334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The isolation and functional characterization of autoimmune clones expressing inappropriate Ia.
    Cronin PS; Sing AP; Glimcher LH; Kelley VE; Reinisch CL
    J Immunol; 1984 Aug; 133(2):822-9. PubMed ID: 6610712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related alterations of the lymphocyte population in the thymus of (NZB x SJL)F1 mice: analysis by flow cytofluorometry.
    Dumont F; Habbersett RC
    Eur J Immunol; 1982 Aug; 12(8):648-52. PubMed ID: 6982815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC; Paul RD; Lopez DM
    J Natl Cancer Inst; 1984 Jul; 73(1):249-55. PubMed ID: 6610791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
    Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delineation of two defects responsible for T-cell hyporesponsiveness to concanavalin A in MRL congenic mice.
    Cameron R; Waterfield JD
    Immunology; 1986 Oct; 59(2):187-93. PubMed ID: 3095226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusual expression of IL 2 receptors and both the c-myb and c-raf oncogenes in T cell lines and clones derived from autoimmune MRL-lpr/lpr mice.
    Rosenberg YJ; Malek TR; Schaeffer DE; Santoro TJ; Mark GE; Steinberg AD; Mountz JD
    J Immunol; 1985 May; 134(5):3120-3. PubMed ID: 3920313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes.
    Sobel ES; Yokoyama WM; Shevach EM; Eisenberg RA; Cohen PL
    J Immunol; 1993 Jan; 150(2):673-82. PubMed ID: 8380429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of lymphoproliferation in MRL-lpr/lpr mice.
    Smathers PA; Santoro TJ; Chused TM; Reeves JP; Steinberg AD
    J Immunol; 1984 Oct; 133(4):1955-61. PubMed ID: 6332142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoregulation in experimental disseminated histoplasmosis: flow microfluorometry (FMF) studies of the Thy and Lyt phenotypes of T lymphocytes from infected mice.
    Watson SR; Miller TB; Redington TJ; Bullock WE
    J Immunol; 1983 Aug; 131(2):984-90. PubMed ID: 6134775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibody in MRL/Mp-lpr/lpr mice. A monoclonal antibody specific for the abnormal T cells from mice bearing the lpr/lpr gene.
    Yamada K; Spezialetti R; Marshak-Rothstein A; Sy MS
    J Immunol; 1989 Apr; 142(8):2702-7. PubMed ID: 2649559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice.
    Davidson WF; Dumont FJ; Bedigian HG; Fowlkes BJ; Morse HC
    J Immunol; 1986 Jun; 136(11):4075-84. PubMed ID: 3009614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rat T lymphocyte antigens comparable with mouse Lyt-1 and Lyt-2,3 antigenic systems: characterization by monoclonal antibodies.
    Matsuura A; Ishii Y; Yuasa H; Narita H; Kon S; Takami T; Kikuchi K
    J Immunol; 1984 Jan; 132(1):316-22. PubMed ID: 6606669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.